TY  - GEN
AU  - Kyrtsonis,Maria-Christina
AU  - Vassilakopoulos,Theodoros P
AU  - Siakantaris,Marina P
AU  - Kokoris,Styliani I
AU  - Gribabis,Despina A
AU  - Dimopoulou,Maria N
AU  - Angelopoulou,Maria K
AU  - Pangalis,Gerassimos A
TI  - Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease
SN  - 0902-4441
PY  - 2004///0513
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Biomarkers, Tumor
KW  - blood
KW  - Bone Resorption
KW  - Cyclophosphamide
KW  - Dexamethasone
KW  - Diphosphonates
KW  - therapeutic use
KW  - Doxorubicin
KW  - Female
KW  - Fibroblast Growth Factor 2
KW  - Follow-Up Studies
KW  - Glycoproteins
KW  - Humans
KW  - Life Tables
KW  - Male
KW  - Melphalan
KW  - Membrane Glycoproteins
KW  - Middle Aged
KW  - Multiple Myeloma
KW  - Neoplasm Proteins
KW  - Neoplasm Staging
KW  - Neovascularization, Pathologic
KW  - Osteoprotegerin
KW  - Pamidronate
KW  - Prednisone
KW  - Prognosis
KW  - Proteoglycans
KW  - Receptors, Cytoplasmic and Nuclear
KW  - Receptors, Tumor Necrosis Factor
KW  - Survival Analysis
KW  - Syndecan-1
KW  - Syndecans
KW  - Vincristine
KW  - beta 2-Microglobulin
KW  - analysis
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1046/j.0902-4441.2003.00205.x
ER  -